Anna-Carin Berggren

Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 μg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: A 12-week, randomized, open-label, controlled, parallel-group noninferiority study

Mats O. Karlsson, Anna-Carin Berggren · Clinical Therapeutics · 2009 · 98 citations

Pain Therapy, Pain Disorders, Pain Medicine +17

The Direct and Indirect Costs of Opioid-Induced Constipation

Frida Hjalte, Anna-Carin Berggren, H. T. G. Bergendahl et al. · Journal of Pain and Symptom Management · 2010 · 81 citations · Full text

Opioid Epidemic, Substance Abuse, Health Sciences +11

Pharmacokinetics of transdermal buprenorphine patch in the elderly

Nabil Al‐Tawil, Ingegerd Odar‐Cederlöf, Anna-Carin Berggren et al. · European Journal of Clinical Pharmacology · 2012 · 58 citations · Full text

Is buprenorphine transdermal patch equally safe and effective in younger and elderly patients with osteoarthritis-related pain? Results of an age-group controlled study

Jón Karlsson, Anna-Lena Söderström, Bengt Go ̈ran Augustini et al. · Current Medical Research and Opinion · 2013 · 22 citations · Full text